Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

NCT03847311 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03847311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03847311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
May 3, 2021
Completion date
October 9, 2023
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chronic pain due to malignancy (finding)